Francesca Palandri

9.3k citations
180 papers · 3.2k indexed · 1 hit paper · h-index 30
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (112 papers)Chronic Myeloid Leukemia Treatments (88 papers)Eosinophilic Disorders and Syndromes (62 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Francesca Palandri

164 papers receiving 3.1k citations

Hit Papers

Nilotinib (formerly AMN107), a highly selective BCR-ABL t...20072026201320192007100200300400500

Peers

Francesca Palandri
Comparison fields: 5 of 95
  • Hematology 2.4k
  • Genetics 2.2k
  • Rheumatology 1.2k
  • Molecular Biology 653
  • Oncology 293
Replace Zbigniew Rudzki with:
Zbigniew Rudzki Australia
François Delhommeau France
S Swanton United Kingdom
Natasha Joan Curtin United Kingdom
Éric Lippert France
Nasios Fourouclas United Kingdom
Clare East United Kingdom
Elisabetta Abruzzese Italy
Paola Guglielmelli Italy
Elisabetta Antonioli Italy
Francesca Palandri relative to Zbigniew Rudzki Australia Zbigniew Rudzki's profile →
Citations per field
00.5×4.4×
Zbigniew Rudzki · 1×
Citations per year

Countries citing papers authored by Francesca Palandri

Since Specialization
Citations

This map shows the geographic impact of Francesca Palandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Palandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Palandri more than expected).

Fields of papers citing papers by Francesca Palandri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Palandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Palandri. The network helps show where Francesca Palandri may publish in the future.

Co-authorship network of co-authors of Francesca Palandri

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Palandri. A scholar is included among the top collaborators of Francesca Palandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Palandri. Francesca Palandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 11
6 1
7 3
8 1
9 0
10 1
11 3
12 1
13 4
14 7
15 4
16 12
17 9
18 5
19 16
20 14

About Francesca Palandri

Francesca Palandri is a scholar working on Genetics, Hematology and Rheumatology, having authored 180 papers that have together received 3.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (112 papers), Chronic Myeloid Leukemia Treatments (88 papers) and Eosinophilic Disorders and Syndromes (62 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (2.2k citations) and Rheumatology (1.2k citations). Francesca Palandri has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Michele Baccarani, Nicola Vianelli, Fausto Castagnetti, Nicola Polverelli, Lucia Catani, Giovanni Martinelli, Giuliana Alimena, Gianantonio Rosti, Gabriele Gugliotta and Simona Soverini. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026